CASSS and the Scientific Organizing Committee are excited to welcome you to Bioassays 2017: Scientific Approaches & Regulatory Strategies and look forward to your participation and input on May 8-9, 2017 at the DoubleTree by Hilton Hotel, Silver Spring, Maryland USA.
Recombinant protein and biological therapeutic products are becoming more complex. The bioassay is a critical element of the control system for this class of therapeutics and is often required to support lot release and stability testing, as well as comparability and characterization studies. Developing robust, QC-suitable bioassays that reflect all the potential mechanisms of action can be challenging, particularly for novel biologic therapeutics or those that incorporate multiple active sites. This is no easy task! As such, bioassays must be scientifically relevant and reflect the mechanism of action. The CASSS Bioassays Symposium provides attendees an interesting view of this exciting class of analytics, along with current technical and regulatory perspectives in an interactive atmosphere.
CASSS Bioassays 2017 is a premier bioassay Symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays. In addition, attendance by regulatory representatives from the US FDA, Health Canada and various European agencies has been strong each year. Participation by both industry and regulatory leaders encourages active discussion and debate on contemporary issues related to bioassays.
The CASSS Bioassays Symposium format incorporates case study presentations as well as a dedicated panel discussion in each session. This format encourages a lively dialogue between all attendees and results in an additional focus on the technical regulatory details of each topic. In addition, a dedicated poster session on Monday afternoon and an Exhibitor Partner Scientific Showcase at the end of day one, gives attendees the opportunity to present additional topics and continue the day’s discussion in an informal setting. The 2017 version of the CASSS Bioassays Symposium promises to maintain the tradition of high quality standard case studies, scientific discussion and networking.
Recombinant protein and biological therapeutic products are becoming more complex. The bioassay is a critical element of the control system for this class of therapeutics and is often required to support lot release and stability testing, as well as comparability and characterization studies. Developing robust, QC-suitable bioassays that reflect all the potential mechanisms of action can be challenging, particularly for novel biologic therapeutics or those that incorporate multiple active sites. This is no easy task! As such, bioassays must be scientifically relevant and reflect the mechanism of action. The CASSS Bioassays Symposium provides attendees an interesting view of this exciting class of analytics, along with current technical and regulatory perspectives in an interactive atmosphere.
CASSS Bioassays 2017 is a premier bioassay Symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays. In addition, attendance by regulatory representatives from the US FDA, Health Canada and various European agencies has been strong each year. Participation by both industry and regulatory leaders encourages active discussion and debate on contemporary issues related to bioassays.
The CASSS Bioassays Symposium format incorporates case study presentations as well as a dedicated panel discussion in each session. This format encourages a lively dialogue between all attendees and results in an additional focus on the technical regulatory details of each topic. In addition, a dedicated poster session on Monday afternoon and an Exhibitor Partner Scientific Showcase at the end of day one, gives attendees the opportunity to present additional topics and continue the day’s discussion in an informal setting. The 2017 version of the CASSS Bioassays Symposium promises to maintain the tradition of high quality standard case studies, scientific discussion and networking.
